1. Zydus Cadila gets approval to market Doxazosin tablets USP, 1 mg, 2 mg, 4 mg, and 8 mg which is used for treatment of high blood pressure and urinary retention associated with enlargement of the prostate gland
2. Zydus Cadila also received tentative approval to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg and is used in the treatment of schizophrenia
3. Jubilant Life Sciences gets approval for anti-depressive drug, Bupropion Hydrochloride extended-release tablets USP (XL), 150 mg and 300 mg, which is used for the treatment of major depressive disorder and prevention of seasonal affective disorder
4. Glenmark gets approval for Olmesartan Medoxomil tablets in multiple strengths of 5 mg, 20 mg and 40 mg, used for the treatment of high blood pressure...
Source: Economic Times